YALE JOURNAL OF BIOLOGY AND MEDICINE 79 2006 pp131140 Copyright 2006 CANCER MECHANISMS The Role MicroRNAs Cancer Carlos E Stahlhut Espinosa Frank J Slack Department Molecular Cellular Developmental Biology Yale University School Medicine New Haven Connecticut Cancer complex dynamic disease involving variety changes gene expression structure Traditionally study cancer focused proteincoding genes sidering principal effectors regulators tumorigenesis Recent advances brought nonproteincoding RNA spotlight MicroRNAs miRNAs class noncoding RNAs implicated regulation cell growth differentiation apoptosis 1 While study early stage mech anism action importance cancer fully understood provide important layer genetic regulation tumorigenesis ultimately valuable therapeutic tools INTRODUCTION C MicroRNAs small noncoding RNAs 18 24 nucleotides discovered 1993 nematode Caenorhabditis el egans Lee et al 2 gene cru cial elegans postembryonic development lin4 code pro tein transcribed 22nu cleotide RNA molecule This molecule repress expression lin14 mRNA directly interacting 3 untranslated region UTR 3 While recognized new method gene regulation initially considered oddity peculiar C elegans The discov ery let7 small RNA involved developmental timing C elegans 4 finding sequence temporal expression pattern largely conserved variety organisms 5 im mediately suggested small RNAs fact play important conserved roles gene regulation identifica tion hundreds miRNAs worm fly mammalian genomes followed 1 To date 300 miRNAs discovered humans computa tional analyses predict 1000 miRNAs exist genome 67 Since miRNAs regulate target estimates indicate able reg ulate 30 percent proteincoding genes human genome 8 highlight ing importance global regulators gene expression miRNA BIOGENESIS AND METHOD OF ACTION MiRNAs transcribed RNA Polymerase II large precursor RNAs kilobases length called pri To correspondence addressed Carlos E Stahlhut Espinosa Frank J Slack Department Molecular Cellular Developmental Biology Yale University School Medicine 266 Whitney Avenue New Haven CT 06520 Tel 2034323493 E mail carlosstahlhutyaleedu frankslackyaleedu Abbreviations miRNAs MicroRNAs mRNA Messenger Ribonucleic Acid 131 132 Espinosa Slack The Role MicroRNAs Cancer miRNAs Notably majority human miRNAs transcribed regions introns proteincoding nonproteincoding transcripts minor ity isolated regions genome exons noncoding mRNA genes 3UTRs mRNA genes In nucleus primiRNAs capped polyadenylated prior processed Drosha member RNase III enzyme family conjunction doublestranded RNAbinding pro tein DGCR8Pasha This processing step produces segments 70 nucleotides length fold stemloop structures known premiRNAs 9 These ex ported nucleus GTPdependent fashion exportin 5 subject additional processing step RNase III enzyme Dicer This step releases dou blestranded RNA duplex 22 nucleotides length turn incorporated miRISC complex analogous fashion observed RNA interference RNAi In complex mature miRNA strand retained complex capable regulating target genes The identification miRNA target transcripts remains greatest chal lenges field today MiRNAs ganized families based sequence homology particularly strong 5 end mature miRNA suggesting section mature transcript pre served evolution plays important role process target recog nition Indeed studies shown 5 gion called miRNA seed crucial stability mature miRNA incorporation miRISC complex 1014 Bioinformatic ap proaches taken advantage miRNA seed predict miRNA targets genome It predicted single miRNA bind 200 different target transcripts notably targets highly diverse transcription factors transporters 1524 miRNA seed Perhaps clear est example let7 complete mature miRNA sequence served species 25 suggesting important role 3 region miRNA target transcript binding Further insights miRNAtarget recognition mechanism needed target prediction accurate ef ficient A POTENTIAL ROLE FOR miRNAS IN CANCER Cancers types share number characteristics loss cellular identity increased ability grow proliferate alterations systems controlling cell death Studies performed variety organisms revealed miRNAs ability regulate cellular processes suggesting involved cancer For instance lin4 let7 control timing devel opmental events C elegans Mutations miRNAs resulted abnormalities cellcycle exit execution terminal differentiation program prevent ing cells reaching fully differen tiated state 2 In Drosophila overexpression Bantam miRNA causes excessive growth wing eye tis sue blocking proapoptotic action gene hid 26 27 It Drosophila miRNA miR14 act strong suppressor apoptosis Deletion miRNA caused increased expression apoptotic effector caspase Drice suggesting direct regulation factor miR14 28 Likewise miR261113308 family Drosophila miRNAs reported induce wide spread apoptosis embryos regulation proapoptotic factors hid grim reaper sickle act inhibition caspase inhibitor Diap1 response number natural toxic conditions 29 There evidence support ing role regions encompassed Another aspect miRNAs ap pear role proper differentia Espinosa Slack The Role MicroRNAs Cancer 133 tion cells different tissues For exam ple miR273 miRNA encoded lys6 shown play important roles patterning C elegans nervous 3031 miR430 implicated brain development 3 The importance miRNA development shown mammalian systems examples miR181 dif ferentiation hematopoietic cells Bcell lineage 33 miR374 pancre atic isletcell development 34 miR143 adipocyte differentiation 35 miR196 limb patterning SHH 36 miR1 heart development 37 miRNAS AS TUMOR SUPPRESSORS miR15a miR161 CLL The study directly suggesting dysregulation miRNA played important role miRNAs tumorigenesis came Calin et al 38 It known loss chromosomal region 13q14 strongly sociated B cell chronic lymphocytic leukemia CLL common form leukemia Western hemisphere gene genes definitely di rectly linked CLL After refining critical region 13q14 30kb Calin et al failed identify protein cod ing genes recognized miRNAs miR15a miR161 clustered chromosomal locus Indeed expression miRNAs diminished completely ablated 65 percent CLL cases examined Further studies revealed germline CtoT mutation seven base pairs downstream miR161 hairpin 75 CLL patients This mutation 160 control individuals Be cause mechanisms miRNA biogenesis fully understood unclear precise effect mutation mutation correlated diminished expression miRNA pa tientderived CLL cells preventing processing miRNA mature form expressed heterologous cell systems 39 loss BCL2 The common loss miR15a miR 161 CLL loss 13q14 mantle cell lymphoma 50 percent cases multiple myeloma 16 40 percent prostate cancer 60 percent 3840 strongly suggests miRNAs act tumor suppressor genes While target complement unknown appear diate effects largely downregulating antiapoptotic protein BCL2 This protein expressed high levels CLL thought important survival malignant cells 41 Consis tent role miRNAs downregulation miR15a miR161 correlates ele vated levels BCL2 heterologous ex pression miRNAs decreased levels endogenous proteins 42 The 3UTR Bcl2 transcript contain binding sites miR15a miR161 reporter structs containing Bcl2 3UTR regulated coexpression miR15a miR161 Moreover expression miRNAs capable inducing apoptosis leukemia cell line Further research nec essary better evaluate miR15a miR161 exert effects mainly BCL2 target additional transcripts CLL Nonetheless evidence available supports important role miR15a miR161 prevention lymphomage nesis leukaemogenesis results The let7 family negatively regulate Ras As noted earlier miRNAs let 7 family scribed experiments performed C elegans provided indication involved cancer Early stud ies showed lossoffunction let7 mu tants defective transition late larval adult stage Upregulation let 7 adult seam cells hand necessary induce cellcycle exit ter minal differentiation If miRNA ab sent differentiate fail undergoing additional rounds division phenomenon observed cancer cells 43 cells 134 Espinosa Slack The Role MicroRNAs Cancer There 12 let7 homologs human genome organized clusters These clusters map fragile sites associated lung breast urothelial cervical cancers suggesting let7 family mem bers act tumor suppressors At clusters confirmed commonly lost malignancies 44 Studies Takamizawa et al Yanaihara et al presented evidence tran scripts certain let7 homologs signif icantly downregulated human lung cancer low levels let7 correlate poor prognosis 4546 Moreover shown transient expression miRNAs let7 family cell lines rived lung adenocarcinomas inhibited colony formation suggesting miRNAs growthsuppressing properties opening possibility let7 therapeutic tool Important insights mechanism let7 capable controlling cellular proliferation came labora tory derived observation let7 family member miR84 negatively reg ulates let60 ortholog human HRAS KRAS NRAS C elegans 47 We shown certain members let 7 family capable genetically interact ing RAS let7 RAS reciprocally expressed lung tumor sam ples We let7 capable negatively regulating RAS human cells overexpression let7 human cancer cell lines results reduced levels RAS protein compared untreated cells As ex pected let7 levels reduced cancer cell lines levels RAS protein increase sig nificantly Moreover use porter constructs confirmed regulation RAS let7 takes place direct interaction miRNA 3UTR Ras mRNA The human RAS family proteins important components myriad signaling cascades shown possess oncogenic activity mutated tumors 48 As studies position let7 promising thera peutic tool treatment lung cancer malignancies resulting overexpression RAS It impor tant carefully analyze specific contributions individual members miRNA family order better stand let7mediated regulation cell growth Other miRNAs acting tumor suppressors Studies implicated miRNAs tumorigenesis MiR143 miR145 instance shown stantly downregulated colorectal tumors 49 recent studies Croce et al shown downregulation miRNAs common occurrence breast carcinomas breast cancer lines 50 Moreover location miRNAs known genomic locus frequently deleted myelodysplastic syndrome 44 While studies ascribed regulation miR143 miR145 colon cancer block Dicer processing 49 studies required determine expression levels miRNAs specifically altered miRNAS AS ONCOGENES Several microRNAs regulate MYC dynamic manner MicroRNAs act oncogenes directly downregulating tumor suppressors indirectly downregulat ing genes act restrict activity known oncogenes An example dynamics interaction tween miR155 MYC oncogene transcription factor ability regu late cell growth induction cell proliferation apoptosis 51 Notably MYC mutated amplified human cancers The miRNA miR155 linked MYC overexpression Bcell cancers suggesting playing role regulation oncogene miR155 encoded nucleotides 241262 BIC originally iden tified transcript derived integra tion site avian leukosis virus Espinosa Slack The Role MicroRNAs Cancer 135 overexpressed Bcell lym phomas 5253 The understanding BIC mediate effects limited years remained unclear presumably nonproteincoding RNA little overall conservation avian murine human genomes consis tently produce lymphomas induce overexpression MYC Metzler et al ana lyzed phylogenetically conserved gions BIC highest homology located 138 nucleotide section gene fact encoded primiRNA miR155 54 Subse quent studies showed miR155 expres sion upregulated 100fold pediatric Burkitt lymphoma Hodgkins lymphoma primary mediastinal cer tain subsets largeB cell lymphomas 55 5656 The role miR155 restricted B cell lymphomas Recent stud ies reported miR155 upregu lated breast lung colon thyroid cancers 5759 It reported mice overexpressing miR155 control Eµ enhancer rapidly develop Bcell malignancy underscoring ability miR155 induce lymphomagenesis requirement major ge netic changes strongly suggesting miR155 act bona fide oncogene 60 Never theless mechanism action miR155 unknown stressing need study miRNA The interaction MYC exclu sive miR155 Recent studies scribed relationship MYC cancer 13q31 locus 6162 This ge nomic locus amplified number cers diffuse largeBcell lymphoma follicular lymphoma mantle cell lymphoma primary cutaneous Bcell lymphoma However gene overexpressed amplicon nonproteincoding RNA C13orf25 63 shown en code miR1792 cluster containing seven miRNAs miR175p miR173p miR18a miR19a miR20a miR19b1 miR92 1 He et al shown cell lines carrying amplification 13q31 analyzed miRNAs increased expression belonged miR1792 cluster 61 Furthermore primiRNA shown miR1792 cluster upregulated 65 cent tested B cell lymphoma samples These data suggested direct involvement miRNA cluster tumorigenesis Further indication involvement miR1792 cluster cancer subsequent experiments miR1719b1 cluster vertebratespe cific segment miR1792 cluster overexpressed retroviral hematopoietic stem cells HSCs mice carrying Myc transgene Lethally irradi ated animals received HSCs express ing miR1719b1 cluster Myc developed malignant lymphomas rap idly receiving HSCs expressing Myc The lymphomas mice ex pressing Myc miR1719b1 characterized increased cell proliferation decreased apoptosis levels com pared malignancies arising mice receiving HSCs Myc Com plementary experiments showed ef fect exclusive miRNAs miR1719b1 cluster individual miRNA cluster unable cause accelerated lymphomagenesis Together results suggest miRNAs com posing miR1719b1 act cooperatively oncogenes presumably targeting proapoptotic antiproliferative factors Independently ODonnell et al identi fied miR1792 cluster group po tentially cancerrelated genes microarray analysis set human mouse rat miRNAs identify miRNAs altered levels human Bcell line overexpresses MYC 62 It MYC induced expression miR1792 cluster Moreover chromatin im munoprecipitation experiments confirm interaction establishing MYC binds intronic region C13orf25 suggesting MYC ability di rectly regulate miR1792 cluster An intriguing scenario suggested bioinformatic prediction members miR1792 cluster miR17 136 Espinosa Slack The Role MicroRNAs Cancer 5p miR20a target transcription fac tor E2F1 E2F1 regulates transition G1 S phase cell cycle regulating genes involved DNA replication cell division apoptosis 64 Notably E2F1 known function reciprocal positivefeedback loop MYC Consis tent inhibition miR175 miR20a cervical cancer derived cell line resulted concomitant increase expression level E2F1 Likewise mutations sites complemen tary miR175p miR20a 3UTR E2F1 resulted increased porter activity compared structs harboring wildtype sequence E2F1s 3UTR These results suggest model MYC induce tran scription miR1792 cluster E2F1 turn miRNAs cluster negatively regulate transcription E2F1 One consequence model miRNAs miR1792 cluster directly regulate effector MYCmediated cell growth An apparent paradox emerges results In presence MYC noted miR1792 cluster function tumor suppressor curbing cellular growth mediated E2F1 contradiction results He et al implicated miR1792 oncogene These results reconciled consider ing E2F1 promote cellular pro liferation reported presence excess levels induce apoptosis 64 As negative regulation E2F1 miRNAs miR1792 cluster fact prevent E2F1 levels reaching thresh old apoptosis triggered acting oncogene supporting MYCmediated proliferation It clear interaction miRNAs targets straightforward initial studies suggested intri cate regulatory networks place cellular There exists possi bility precise role miR1792 given cell depends miRNAs present turn affected spatial temporal considerations miRNA SIGNATURES AND DETECTION METHODS The multiple lines evidence indicat ing microRNAs differentially ex pressed normal tumor samples suggest miRNAs serve useful tumor profiling tools Indeed profiling stud ies shown cancer type pos sesses distinct miRNA expression signature signature provide useful information malignancy The adaptation highthroughput technolo gies facilitated study expres sion multiple miRNAs given sample making possible profile substantial sam ple numbers relative ease Among important methods miRNA profil ing use oligonucleotide miRNA mi croarray researcher simultaneously determine expression levels hundreds miRNAs given sample 6567 Multiple variations technique developed derscoring position central miRNA profiling tool 6871 Other important ap proaches problem available quantitative PCR precursor miRNAs 72 mature miRNAs 7374 genomewide approaches serial analy sis gene expression SAGE mi RAGE 75 flow cytrometric techniques 76 analysis beadbased allows Taking advantage tools groups studied miRNA expression types cancer Michael et al 49 Cummins et al 75 studied ex pression profile known miRNAs colorectal cancer samples These studies dependently general downregula tion miRNA levels tumor cells compared normal colonic epithelium observing significant decrease levels miR143 miR145 yond general effect Cummins et al signature 50 differentially ex pressed miRNAs malignant vs normal colonic epithelium 32 miRNAs reduced levels tumor cells Yanaihara et al studied 100 patientmatched pairs primary malignant normal adjacent lung tissue expression Espinosa Slack The Role MicroRNAs Cancer 137 43 miRNAs significantly different tumor tissues compared normal adjacent tissues Of miRNAs 28 downregulated 15 upregulated malignant tissue 46 Similar studies carried CLL 77 breast cancer 50 glioblastoma 78 pancreatic cancer 79 hepatocellular carcinoma 80 thyroid papillary carcinoma 58 The ability profile miRNA ex pression tumor accuracy repro ducibility clinical setting constitute valuable medical tool Indeed miRNA profiles shown highly informative Using beadbased ap proach Lu et al attempted classify 17 poorly differentiated tumors nondiag nostic histological appearance based miRNA expression profiles A clinical diag nosis tumors established anatomical context directly pri mary tumor observed given organ indirectly metastasis previously iden tified primary tumor They able cor rectly diagnose 12 17 samples 117 correct diagnoses analysis mRNA profile 76 While number transcripts analyzed smaller miRNAs mRNAs 200 15000 possible miRNAbased diagnoses accurate regulatory role molecules mRNAs regulatory na ture Further studies necessary ascertain value miRNAs diag nostic tools potential value prognostic markers correlating miRNA expression typespecific parameters metastatic potential proliferative index response existing treatments CLOSING REMARKS miRNAS AS TREATMENT TARGETS While field miRNAs par ticularly study roles miRNAs cancer early stage poten tial targeted therapeutic tools gone unnoticed A promising approach target oncogenic miRNAs oligonucleotides complementary mature function precursor sequence deemed antimiRNA oligonucleotides AMOs A number chemical modifications oligonu cleotides available purpose making stable toxic 2 Omethylated AMOs common form modified RNA conferring limited nuclease resistance enhancing binding affinity RNA Inhibition let7 31nucleotide 2OMe AMOs demonstrated HeLa cells C elegans larvae 81 2OMe AMOs reported abro gate miRNA function cellular assays 8283 providing proofofprinciple blockage miRNA function extraneous oligomers Another common modification structure AMOs locked nucleic acid LNAmodified oligomers In RNAs 2 oxygen atom linked 4 position methylene bridge forming rigid bicyclic structure locked C3endo RNA sugar conformation 84 This modification results greatly en hanced affinity RNA formation exceedingly strong duplexes excel lent mismatch discrimination properties 85 87 This makes prime candidates AMObased therapy results rodents encouraging 88 While use AMOs useful inhibit oncogenic miRNAs ther apeutic possibility concerns cases certain miRNAs underexpressed let7 lung cancer miR15a mir161 CLL In case synthetic miRNAs likely modified discussed mature precursor form delivered target cells counteract deficiency halt malignant growth While approach tempted cell culture 89 testing animal models required A pressing challenge use miRNAs therapeutic tools concerns ing methods deliver synthetic miRNAs AMOs desired tissues targeted effective manner Given mol ecules discriminate healthy malignant cells effects treatment remain concern Likewise 138 Espinosa Slack The Role MicroRNAs Cancer studies infancy little known pharmacokinetics AMOs synthetic miRNAs limiting discussion promise therapeutic tools speculative arena Upon reaching deeper understanding mechanism miRNA biogenesis action development new delivery technologies small RNAs fulfill promise valuable therapeutics REFERENCES 1 EsquelaKerscher A Slack FJ Oncomirs microRNAs role cancer Nat Rev Cancer 20066425969 2 Lee RC Feinbaum RL Ambros V The C el egans heterochronic gene lin4 encodes small RNAs antisense complementarity lin 14 Cell 199375584354 3 Wightman B Ha I Ruvkun G Posttranscrip tional regulation heterochronic gene lin14 lin4 mediates temporal pattern mation C elegans Cell 19937585562 4 Reinhart BJ Slack FJ Basson M Pasquinelli AE Bettinger JC Rougvie AE et al The 21 nucleotide let7 RNA regulates developmen tal timing caenorhabditis elegans Nature 200040367729016 5 Pasquinelli AE Reinhart BJ Slack F Martin dale MQ Kuroda MI Maller B et al Con servation sequence temporal expression let7 heterochronic regulatory RNA Nature 20004086808869 6 Bentwich I Avniel A Karov Y Aharonov R Gilad S Barad O et al Identification hun dreds conserved nonconserved human microRNAs Nat Genet 200537776670 7 Berezikov E Guryev V van Belt J Wien holds E Plasterk RH Cuppen E Phyloge netic computational identification human microRNA genes Cell 20051201214 shadowing 8 Lewis BP Burge CB Bartel DP Conserved seed pairing flanked adenosines indicates thousands human genes microRNA targets Cell 200512011520 9 Cai X Hagedorn CH Cullen BR Human mi processed capped croRNAs polyadenylated transcripts func tion mRNAs RNA 200410195766 10 Khvorova A Reynolds A Jayasena SD Functional siRNAs miRNAs exhibit strand bias Cell 200311520916 11 Schwarz DS Asymmetry assembly complex Cell enzyme RNAi 2003115199208 12 Doench JG Sharp PA Specificity mi croRNA target selection translational pression Genes Dev 20041850411 13 Vella MC Choi EY Lin SY Reinert K Slack FJ The C elegans microRNA let7 binds imperfect let7 complementary sites lin41 3UTR Genes Dev 20041821327 14 Brennecke J Stark A Russell RB Cohen SM Principles microRNAtarget recogni tion PLoS Biol 20053e85 15 Lim LP Microarray analysis shows microRNAs downregulate large numbers target mRNAs Nature 200543376973 16 Lim LP The microRNAs caenorhabditis elegans Genes Dev 2003179911008 17 Grosshans H Johnson T Reinert KL Ger stein M Slack FJ The temporal patterning microRNA let7 regulates transcrip tion factors larval adult transition C elegans Dev Cell 20058332130 18 Krek A Combinatorial microRNA target pre dictions Nature Genet 200537495500 19 Rehmsmeier M Steffen P Hochsmann M Giegerich R Fast effective prediction RNA microRNAtarget 200410150717 duplexes 20 John B Human microRNA targets PLoS Biol 20042e363 21 Kiriakidou M A combined computationalex perimental approach predicts human mi Dev croRNA 200418116578 targets Genes 22 Enright AJ MicroRNA targets drosophila Genome Biol 20035R1 23 Rajewsky N Socci ND Computational iden tification microRNA targets Dev Biol 200426752935 24 Rajewsky N MicroRNA target predictions animals Nature Genet 200638 SupplS8 S13 25 Pasquinelli A Reinhart B Slack F Maller B Ruvkun G Conservation animal phy logeny sequence temporal regula tion 21 nucleotide C elegans let7 heterochronic regulatory RNA Nature 2000408869 26 Brennecke J Hipfner DR Stark A Russell RB Cohen SM Bantam encodes develop mentally regulated microRNA controls cell proliferation regulates proapop totic drosophila Cell 20031132536 gene hid 27 Hipfner DR Weigmann K Cohen SM The bantam gene regulates drosophila growth Genetics 200216115271537 28 Xu P Vernooy SY Guo M Hay BA The drosophila microRNA mir14 suppresses cell death required normal fat metabo lism Curr Biol 2003137905 29 Leaman D Chen PY Fak J Yalcin A Pearce M Unnerstall U et al Antisensemediated depletion reveals essential specific func tions microRNAs drosophila develop ment Cell 200512171097108 30 Johnston RJ Hobert O A microRNA control asymmetry Nature ling leftright neuronal caenorhabditis 20034268459 elegans 31 Chang S Johnston RJ FrokjaerJensen C Lockery S Hobert O MicroRNAs act se quentially asymmetrically control Espinosa Slack The Role MicroRNAs Cancer 139 chemosensory laterality nematode Na ture 20044307859 32 Giraldez AJ MicroRNAs regulate brain mor Science zebrafish phogenesis 20053088338 33 Chen CZ Li L Lodish HF Bartel DP Mi croRNAs modulate hematopoietic lineage differentiation Science 2004303836 34 Poy MN A pancreatic isletspecific mi croRNA regulates insulin secretion Nature 200443222630 35 Esau C MicroRNA143 regulates adipocyte dif ferentiation J Biol Chem 2004279523615 36 Hornstein E The microRNA miR196 acts upstream Hoxb8 shh limb develop ment Nature 20054386714 targets Hand2 37 Zhao Y Samal E Srivastava D Serum sponse factor regulates musclespecific mi croRNA cardiogenesis Nature 200543621420 38 Calin GA Frequent deletions downregu lation microRNA genes miR15 miR16 13q14 chronic lymphocytic leukemia Proc Natl Acad Sci USA 200299155249 39 Calin GA A microRNA signature associated prognosis progression chronic lymphocytic leukemia N Engl J Med 20053531793801 40 Dong JT Boyd JC Frierson HF Jr Loss heterozygosity 13q14 13q21 high grade high stage prostate cancer Prostate 200149316671 41 SanchezBeato M SanchezAguilera A Piris MA Cell cycle deregulation Bcell lym phomas Blood 2003101122035 42 Cimmino A Calin GA Fabbri M Iorio MV Ferracin M Shimizu M miR15 miR16 induce apoptosis targeting BCL2 Proc Natl Acad Sci USA 2005102139449 43 Reinhart BJ Slack FJ Basson M Pasquinelli AE Bettinger JC Rougvie AE The 21nu cleotide let7 RNA regulates developmental timing caenorhabditis elegans Nature 20004039016 44 Calin GA Sevignani C Dumitru CD Hyslop T Noch E Yendamuri S Human microRNA genes frequently located fragile sites genomic regions involved cancers Proc Natl Acad Sci USA 200410129993004 45 Takamizawa J Konishi H Yanagisawa K To mida S Osada H Endoh H Reduced expres sion let7 microRNAs human lung cancers association shortened postop erative survival Cancer Res 20046437536 46 Yanaihara N Caplen N Bowman E Seike M Kumamoto K Yi M Unique microRNA mo lecular profiles lung cancer diagnosis prognosis Cancer Cell 2006918998 47 Johnson SM Grosshans H Shingara J Byrom M Jarvis R Cheng A RAS regu lated let7 microRNA family Cell 200512063547 48 Malumbres M Barbacid M RAS oncogenes The 30 years Nat Rev Cancer 2003345965 49 Michael MZ SM OC van Holst Pellekaan NG Young GP James RJ Reduced accumu lation specific microRNAs colorectal neoplasia Mol Cancer Res 2003188291 50 Iorio MV Ferracin M Liu CG Veronese A Spizzo R Sabbioni S MicroRNA gene ex pression deregulation human breast cancer Cancer Res 200565706570 51 Pelengaris S Khan M Evan GI Suppression mycinduced apoptosis beta cells ex poses multiple oncogenic properties myc triggers carcinogenic progression Cell 200210932134 52 Clurman BE Hayward WS Multiple proto oncogene activations avian leukosis virusin duced lymphomas Evidence stagespecific events Mol Cell Biol 1989926572664 53 Tam W BenYehuda D Hayward WS Bic novel gene activated proviral insertions avian leukosis virusinduced lymphomas likely function noncoding RNA Mol Cell Biol 1997171490502 54 Metzler M Wilda M Busch K Viehmann S Borkhardt A High expression precursor mi croRNA155BIC RNA children Burkitt lymphoma Genes Chromosomes Can cer 2004391679 55 Eis PS Accumulation miR155 BIC RNA human B cell lymphomas Proc Natl Acad Sci USA 2005102362732 56 Kluiver J BIC miR155 highly ex pressed Hodgkin primary mediastinal diffuse large B cell lymphomas J Pathol 20052072439 57 Eis PS Tam W Sun L Chadburn A Li Z Gomez MF Accumulation miR155 BIC RNA human B cell lymphomas Proc Natl Acad Sci USA 2005102362732 58 He H Jazdzewski K Li W Liyanarachchi S Nagy R Volinia S The role microRNA genes papillary thyroid carcinoma Proc Natl Acad Sci USA 20051021907580 59 Volinia S Calin GA Liu CG Ambs S Cim mino A Petrocca F A microRNA expression signature human solid tumors defines cer gene targets Proc Natl Acad Sci USA 2006103225761 60 Costinean S Pre B cell proliferation lym phoblastic leukemiahigh grade lymphoma emiu miR 155 transgenic mice Proc Natl Acad Sci USA 200610370249 61 He L Thomson JM Hemann MT Hernando Monge E Mu D Goodson S A microRNA polycistron potential human oncogene Nature 200543582833 62 ODonnell KA Wentzel EA Zeller KI Dang CV Mendell JT cmycregulated microR NAs modulate E2F1 expression Nature 200543583943 63 Ambros V Control developmental timing caenorhabditis elegans Curr Opin Genet Dev 20001042833 64 Trimarchi JM Lees JA Sibling rivalry E2F family Nature Rev Mol Cell Biol 200231120 140 Espinosa Slack The Role MicroRNAs Cancer 65 Kim VN Nam JW Genomics microRNA Trends Genet 20062216573 66 Liu CG An oligonucleotide microchip genomewide microRNA profiling human mouse tissues Proc Natl Acad Sci USA 200410197404 67 Hammond SM MicroRNA detection comes age Nature Methods 200631213 68 Liang RQ Li W Li Y Tan CY Li JX Jin YX An oligonucleotide microarray mi croRNA expression analysis based label ing RNA quantum dot nanogold probe Nucleic Acids Res 200533e17 69 Thomson JM Parker J Perou CM Hammond SM A custom microarray platform analy sis microRNA gene expression Nat Meth ods 200414753 70 EsquelaKerscher A Slack FJ The age highthroughput microRNA profiling Nat Methods 2004121067 71 Barad O Meiri E Avniel A Aharonov R Barzilai A Bentwich I MicroRNA expres sion detected oligonucleotide microarrays System establishment expression profil ing human tissues Genome Res 200414248694 72 Schmittgen TD Jiang J Liu Q Yang L A highthroughput method monitor ex pression microRNA precursors Nucleic Acids Res 200432e43 73 Chen C Ridzon DA Broomer AJ Zhou Z Lee DH Nguyen JT Realtime quantification microRNAs stemloop RTPCR Nu cleic Acids Res 200533e179 74 Raymond CK Roberts BS GarrettEngele P Lim LP Johnson JM Simple quantitative primerextension PCR assay direct mon itoring microRNAs shortinterfering RNAs RNA 200511173744 75 Cummins JM He Y Leary RJ Pagliarini R Diaz LA Jr Sjoblom T The colorectal mi croRNAome Proc Natl Acad Sci USA 2006103368792 76 Lu J Getz G Miska EA AlvarezSaavedra E Lamb J Peck D MicroRNA expression profiles classify human cancers Nature 20054358348 77 Calin GA MicroRNA profiling reveals dis tinct signatures B cell chronic lymphocytic leukemias Proc Natl Acad Sci USA 20041011175560 78 Ciafre SA Galardi S Mangiola A Ferracin M Liu CG Sabatino G Extensive modula tion set microRNAs primary glioblastoma Biochem Biophys Res Com mun 200533413518 79 Roldo C Missiaglia E Hagan J Falconi M Capelli P Bersani S et al MicroRNA expres sion abnormalities pancreatic endocrine acinar tumors associated distinc tive pathological features clinical behav ior J Clin Oncol 200624467784 80 Murakami Y Comprehensive analysis mi croRNA expression patterns hepatocellular carcinoma nontumorous tissues Onco gene 200625253745 81 Hutvagner G Simard MJ Mello CC Zamore PD Sequencespecific inhibition small RNA function PLoS Biol 20042E98 82 Cheng AM Byrom MW Shelton J Ford LP Antisense inhibition human miRNAs indications involvement miRNA cell growth apoptosis Nucleic Acids Res 20053312907 83 Meister G Landthaler M Dorsett Y Tuschl T Sequencespecific inhibition microRNA siRNAinduced RNA silencing RNA 20041054450 84 Vester B Wengel J LNA locked nucleic acid Highaffinity targeting complemen tary RNA DNA Biochemistry 2004431323341 85 Childs JL Disney MD Turner DH Oligonu cleotide directed misfolding RNA inhibits candida albicans group I intron splicing Proc Natl Acad Sci USA 200299110916 86 Elayadi AN Braasch DA Corey DR Impli cations highaffinity hybridization locked nucleic acid oligomers inhibition telomerase Biochemistry human 200241997381 87 Mouritzen P Nielsen AT Pfundheller HM Choleva Y Kongsbak L Moller S Single nu cleotide polymorphism genotyping locked nucleic acid LNA Expert Rev Mol Diagn 200332738 88 Fluiter K Asbroek AL Wissel MB Jakobs ME Wissenbach M Olsson H In vivo tumor growth inhibition biodistrib ution studies locked nucleic acid LNA antisense oligonucleotides Nucleic Acids Res 20033195362 89 Johnson SM Grosshans H Shingara J Byrom M Jarvis R Cheng A et al RAS regulated let7 microRNA family Cell 2005120563547